Skip to main content

AIBD 2022 Main banner

Tweets by AIBD 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Industry Theater

Non-CME Innovation Theaters

Identifying and Treating Appropriate Moderate to Severe UC Patients

Wednesday, December 7, 2022

6:30 AM – 7:30 AM

Location: Northern Hemisphere D

Speaker(s)

Anita Afzali, MD, MPH, MHCM, FACG, AGAF

Professor of Medicine; Executive Vice Chair of Internal Medicine; Associate Chief Medical Officer of UC Health and Cincinnati Children's Hospital
University of Cincinnati
Cincinnati, Ohio

Non-Accredited session.

Session supported by Bristol Myers Squibb.

Learning Objectives:

Provide an overview of a treatment option for UC and review key efficacy and safety data from a phase 3 clinical trial and ongoing open-label extension trial
Examine clinically relevant patient cases